DTL
TCRT icon

Dynamic Technology Lab’s Alaunos Therapeutics TCRT Stock Holding History

Dynamic Technology Lab’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-203
Closed -$100K – 1335
2020
Q2 		$100K Buy
+203
New +$90.5K 0.02% 888

Other funds holding TCRT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dynamic Technology Lab's TCRT Position: Q3 2020 in Review

Dynamic Technology Lab sold out of Alaunos Therapeutics (TCRT) in Q3 2020, closing a stake of 203 shares — an estimated $100K sold.

Dynamic Technology Lab first reported a position in TCRT in Q2 2020 and held it in 1 quarter. The position peaked at $100K in Q2 2020. 154 funds tracked by Wall St. Rank hold TCRT as of Q3 2020.

  • Dynamic Technology Lab reported no remaining Alaunos Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Dynamic Technology Lab sold 203 Alaunos Therapeutics shares in Q3 2020, an estimated $100K.
  • Dynamic Technology Lab first reported a position in Alaunos Therapeutics in Q2 2020 and held it in 1 quarter.
  • Dynamic Technology Lab's Alaunos Therapeutics position peaked at $100K in Q2 2020.
  • 154 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2020.

Based on Dynamic Technology Lab's 13F filing for Q3 2020, filed 13 Nov 2020.